Observational study on phage therapy requests for bone infections
Official title: Avis-PHAGEinLYON Clinic
Run by Hospices Civils de Lyon · NCT05883995 · Data updated 2026-11-12
This study looks at how many patients are asking for phage therapy to treat bone infections over a period of time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 1500 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 1 site (Lyon) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | February 1, 2028 |
| Study ends | February 1, 2029 |
| Registry record updated | June 1, 2023 |
| Trial ID | NCT05883995 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients referred to the Hospices Civils de Lyon specifically for phage therapy requests between 2015 and 2028.
✕Probably not a fit
Patients who oppose participation in the trial will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Avis-PHAGEinLYON Clinic is a non-interventional observational study conducted at the Hospices Civils de Lyon, focusing on patients referred for medical advice regarding phage therapy for bone infections. This study aims to quantify the number of phage therapy requests received from 2015 to 2028, including both retrospective and prospective data collection. A total of 1500 patients will be included to provide insights into the demand and potential application of phage therapy in treating bone infections.
Why it matters
Potential benefit: If successful, this study could enhance understanding and accessibility of phage therapy for patients suffering from bone infections.
How similar studies have gone: While phage therapy is a novel approach, there have been limited studies exploring its effectiveness, making this study particularly significant in understanding its application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * \- Patient referred to the Hospices Civils de Lyon for a phage therapy request from 01/01/2015 to 01/01/2028. * Avis-PHAGEinLYON clinic study information notice provided to the patient Exclusion Criteria: * \- Opposition of trial participant
Where it's running
-
Centre de Référence des Infections Ostéo-Articulaires complexes (CRIOAc) - Hôpital de la Croix-Rousse
Lyon, France Recruiting
Study contacts
- Study coordinator: Tristan FERRY, MD
- Email: Tristan.ferry@chu-lyon.fr
- Phone: 0033 4.72.07.11.07
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral antibiotics for treating bone and joint infections in children
This study is testing if giving oral antibiotics first can effectively and safely treat uncomplicated bone and joint infections in children and teens aged 3 months to 17 years.
-
Oral antibiotics for treating bone and joint infections in children
This study tests if giving only oral antibiotics can effectively treat bone and joint infections in children, compared to the usual method that starts with IV antibiotics.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.